Migraineurs tend to have more anxiety when it comes to dental procedures compared with those without migraine.
Migraineurs suffer a significant difference in anxiety levels regarding dental treatment compared with nonmigraine controls, according to results of a new study. Findings were published in the Journal of Medicine and Life.
Anxiety is a common comorbidity among migraineurs, while dental anxiety is frequently encountered in the practice and can lead to delay or avoidance of dental care, the authors explained.
To better understand the relationship between migraine and dental anxiety, researchers carried out a cross-sectional study among 171 Saudi patients. Of the participants included, 83 suffered from migraine.
Migraineurs were matched to control patients based on age and sex. All participants visited specific dental clinics and filled out a validated questionnaire: the Modified Dental Anxiety Scale – Arabic version. Participant responses ranged from “not anxious” (scoring 1) to “extremely anxious” (scoring 5), the researchers explained.
Responses revealed:
Based on their findings, the researchers suggested dentists use more quiet hand pieces during dental procedures, while soundproof earplugs may help reduce the potential of headaches among migraineurs.
“The clinics could use more dimmed lighting; also, placing the waiting areas far away from the operating rooms could help to help reduce stress, which helps lower migraine triggers,” they added. “Well-ventilated operating rooms and waiting areas could reduce the smell that usually is a migraine trigger.”
The higher number of females included in the study and that patients were recruited from a single center mark limitations to the analysis.
“There is a significant difference in the anxiety levels of migraine patients regarding dental treatment, and there is a need to include migraine in the history taken prior to treatment procedures and modify the dental work environment accordingly,” the authors concluded.
Future studies should include patients at multiple clinics and focus on including the number of male participants.
Reference
Alyami YD, Farran JK, Alsubhi JA, et al. Dental anxiety among migraine patients. J Med Life. 2021;14(4):498-503. doi:10.25122/jml-2021-0004
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
CGRP Inhibitors: A Promising New Class of Drugs for Migraine
November 14th 2018This fall, The American Journal of Managed Care® convened a panel of experts on migraine to discuss calcitonin gene-related peptide (CGRP) inhibitors, an emerging therapy for the condition, which affects 39 million people in the United States.
Listen